Pharmaceutical

Xeris Pharmaceuticals Completes Acquisition of Strongbridge Biopharma

CHICAGO–(COMMERCIAL THREAD) – Xeris Pharmaceuticals, Inc. (“Xeris”), a pharmaceutical company leveraging its new formulation technology platforms to develop and market ready-to-use injectable drug formulations, today announced that it has finalized with successfully completed the previously announced acquisition of Strongbridge Biopharma plc (Nasdaq: SBBP) (“Strongbridge”). Pursuant to the Acquisition Agreement, the …

Read More »

Ways they can earn income from new pharmaceuticals

Pharmaceuticals are drugs used to treat or prevent illnesses. As the medical field is constantly evolving, new pharmaceutical products are constantly being developed. Some of these pharmaceuticals include vaccines, antibiotics, and birth control pills. These medicines can be taken as tablets or by injection depending on the type of medicine …

Read More »

Part 1. Conventional SPC Rules and Pharmaceutical Process Data

The first part of this series of articles demonstrates, using real-world process data, that the four fundamental assumptions underlying classic Shewhart control charts (randomness, independence, constant mean and constant variation) do not are often not met. European Union (EU) Good Manufacturing Practices (GMP) and FDA regulatory documents require manufacturers to …

Read More »

Danbury Pharmaceuticals ‘Unlocks’ $ 100 Million in Manufacturing Plant Sale-Leaseback

September 30, 2021 1of6 MannKind Corp. Manufacturing Plant on Casper Street. Contribution photoShow moreShow less 2of6 Karine Fabio, chemist at MannKind, works in the analytical department on Tuesday January 26, 2016. Carol Kaliff / Hearst Connecticut MediaShow moreShow less 3of6 4of6 Mannkind Corporation manufacturing facilities in Danbury, Connecticut. H John …

Read More »

CytoReason and Summit Pharmaceuticals International Announce Introducing AI Platform at One of Japan’s Top Pharmaceutical Companies

TOKYO and TEL AVIV, Israel, September 30, 2021 / PRNewswire / – CytoReason, an AI company that develops computational disease models for clinical drug discovery and development, and International Pharmaceutical Summit (SPI), a Japanese company providing services and products to the pharmaceutical industry (a 100% subsidiary of Sumitomo Corporation), today …

Read More »